Proteasome inhibitor PS519 reduces infarction and attenuates leukocyte infiltration in a rat model of focal cerebral ischemia

Stroke

Volumn 31, Issue 7, 2000, Pages 1686-1693

  Phillips, James B ^a,b   Williams, Anthony J ^a   Adams, Julian ^c   Elliott, Peter J ^c   Tortella, Frank C ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b NATIONAL RESEARCH COUNCIL   (United States)

^c ProScript   (United States)

Author keywords

Cerebral ischemia; Enzyme inhibitors; Neuroprotection; Rats

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEASOME INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; CELL INFILTRATION; ELECTROENCEPHALOGRAM; LEUKOCYTE; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME;

EID: 0033918122     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.31.7.1686     Document Type: Article

References (38)

1. Chen H, Chopp M, Schultz L, Bodzin G, Garcia JH. Sequential neuronal and astrocytic changes after transient middle cerebral artery occlusion in the rat. J Neurol Sci. 1993;118:109-116.
2. Barone FC, Schmidt DB, Hillegass LM, Price WJ, White RF, Feuerstein GZ, Clark RK, Lee EV, Griswold DE, Sarau HM. Reperfusion increases neutrophils and leukotriene B4 receptor binding in rat focal ischemia. Stroke. 1992;23:1337-1347.
3. Matsuo T, Onodere H, Shiga Y, Nakamura M, Ninomiya M, Kihar T, Kogure K. Correlation between myeloperoxidase-quantified neutrophil accumulation and ischemic brain injury in the rat. Stroke. 1994;25: 1469-1475.
4. Zhang R-L, Chopp M, Chen H, Garcia JH. Temporal profile of ischemic tissue damage, neutrophil response, and vascular plugging following permanent and transient (2H) middle cerebral artery occlusion in the rat. J Neurol Sci. 1994;125:3-10.
5. Wang X, Feuerstein GZ. Induced expression of adhesion molecules following focal brain ischemia. J Neurotrauma. 1995;12:825-832.
6. Yoshimoto T, Houkin K, Tada M, Abe H. Induction of cytokines, chemokines and adhesion molecule mRNA in a rat forebrain reperfusion model. Acta Neuropathol. 1997;93:154-158.
7. Pantoni L, Sarti C, Domenico I. Cytokines and cell adhesion molecules in cerebral ischemia: experimental bases and therapeutic perspectives. Arterioscler Thromb Vasc Biol. 1998;18:503-513.
8. Chopp M, Zhang RL, Chen H, Li Y, Jiang N, Rusche JR. Postischemic administration of an anti-Mac-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in rats. Stroke. 1994;25: 869-875.
9. Garcia JH, Liu K-F, Relton JK. Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion. Am J Pathol. 1995;147:1477-1486.
10. Palmonbella VJ, Rando OJ, Goldberg AL, Maniatis T. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell. 1994;78:773-785.
11. Beg AA, Baltimore, D. An essential role for NF-κB in preventing TNF-α-induced cell death. Science. 1996;274:782-784.
12. Read MA, Neish AS, Luscinskas FW, Palombella VJ, Maniatis T, Collins T. The proteasome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression. Immunity. 1995;2:493-506.
13. Fenteany G, Standaert RF, Lane WS, Choi S, Corey EJ, Schreiber SL. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science. 1995;268:726-731.
14. Soucy F, Plamondon L, Behnke M, Roush W. Synthesis of clastolactacystin β-lactone and analogs thereof. J Am Chem Soc. 1999;121: 9967-9976.
15. Campbell B, Adams J, Shin YK, Lefer AM. Cardioprotective effects of a novel proteasome inhibitor following ischemia and reperfusion in the isolated perfused rat heart. J Mol Cell Cardiol. 1999;31:467-476.
16. Conner EM, Brand S, Davis JM, Laroux FS, Palombella VJ, Fuseler JW, Kang DY, Wolf RE, Grisham MB. Proteasome inhibition attenuates nitric oxide synthase expression, VCAM-1 transcription and the development of chronic colitis. J Pharmacol Exp Ther. 1997;282:1615-1622.
17. Elliott PJ, Pien CS, McCormack TA, Chapman ID, Adams J. Proteasome inhibition: a novel mechanism to combat asthma. J Asthma Clin Immunol. 1999;104:294-300.
18. Vanderlugt CL, Rahbe SM, Elliott PJ, Dal Canto MC, Miller SD. Treatment of established relapsing experimental autoimmune endophalomyelitis with the proteasome inhibitor PS-519. J Neuroimmunol. In press.
19. Britton P, Lu X-C, Laskosky M, Tortella FC. Dextromethorphan protects against cerebral injury following transient, but not permanent, focal ischemia in rats. Life Sci. 1997;60:1729-1740.
20. Prophet EB. In: AFIP Staff, eds. AFIP Laboratory Methods in Histotechnology. Washington, DC: American Registry of Pathology; 1992:29-31.
21. Belayev L, Alonso OF, Busto R, Zhao W, Ginsberg MD. Middle cerebral artery occlusion in the rat by intraluminal suture. Stroke. 1996;27: 1616-1623.
22. Schmid-Elsaesser R, Zausinger S, Hungerhuber E, Baethmann A, Reulen H-J. A critical reevaluation of the intraluminal thread model of focal cerebral ischemia. Stroke. 1998;29:2162-2170.
23. Ringelstein EB, Biniek R, Weiller C, Ammeling B, Nolte PN, Thron A. Type and extent of hemispheric brain infarctions and clinical outcome in early and delayed middle cerebral artery recanalization. Neurology. 1992; 142:289-298.
24. Hallenbeck JM, Dutka AJ. Background review and current concepts of reperfusion injury. Arch Neurol. 1990;47:1245-1254.
25. Minami M, Kuraishi Y, Yabuuchi K, Yamazaki A, Satoh M. Induction of interleukin-1β mRNA in rat brain after transient forebrain ischemia. J Neurochem. 1992;58:390-392.
26. Palombella VJ, Conner EM, Fuseler JW, Destree A, Davis JM, Laroux FS, Wolf RE, Huang J, Brand S, Elliott P, Lazarus D, McCormack T, Parent L, Stein R, Adams J, Grisham MB. Role of the proteasome and NF-κB in streptococcal cell wall-induced polyarthritis. Proc Natl Acad Sci U S A. 1998;95:15671-15676.
27. Bethea JR, Castro M, Keane RW, Lee TT, Dietrich WD, Yezierski RP. Traumatic spinal cord injury induces nuclear factor-κB activation. J Neurosci 1998;18:3251-3260.
28. Blight AR, Cohen TI, Saito K, Heyes MP. Quinolinic acid accumulation and functional deficits following experimental spinal cord injury. Brain. 1995;118:735-752.
29. Schneider A, Martin-Villalba A, Weih F, Vogel J, Wirth T, Schwaninger M. NF-κB is activated and promotes cell death in focal cerebral ischemia. Nat Med. 1999;5:554-559.
30. Clemens JA, Stephenson DT, Yin T, Smalstig EB, Panetta JA, Little SP. Drug-induced neuroprotection from global ischemia is associated with prevention of persistent but not transient activation of nuclear factor-κB in rats. Stroke. 1998;29:677-682.
31. Kaltschmidt C, Kaltschmidt B, Baeuerle PA. Stimulation of inotropic glutamate receptors activates transcription factor NF-κB in primary neurons. Proc Natl Acad Sci U S A. 995;92:9618-9622.
32. Garcia-Ruiz C, Colell A, Morales A, Kaplowitz N, Fernandez-Cheza JC. Role of oxidative stress generated from the mitochondrial electron transport chain and mitochondrial glutathione status in loss of mitochondrial function and activation of transcription factor nuclear factor-κB: studies with isolated mitochondria and rat hepatocytes. Mol Pharmacol. 1995;48:825-834.
33. Koroshetz WJ, Moskowitz MA. Emerging treatments for stroke in humans. Trends Pharmacol Sci. 1996;17:227-233.
34. Alberts MJ. tPA in acute ischemic stroke, United States experience and issues for the future. Neurol. 1998;51:S53-S55.
35. De Keyser J, Sulter G, Luiten PG. Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing? Trends Neurosci. 1999;22:535-540.
36. Margaill I, Parmentier S, Callebert J, Allix M, Boulu RG, Plotkine M. Short therapeutic window for MK-801 in transient focal cerebral ischemia in normotensive rats. J Cereb Blood Flow Metab. 1996;16: 107-113.
37. Cregan EF, Peeling J, Corbett D, Buchan AM, Saunders J, Auer RN, Gao J, McCarthy DJ, Eisman MS, Campbell TM, Murray RJ, Stagnitto ML, Palmer GC. [(S)-Alpha-phenyl-2-pyridine-ethanamine dihydrochloride], a low affinity uncompetitive N-methyl-D-aspartic acid antagonist, is effective in rodent models of global and focal ischemia. J Pharmacol Exp Ther. 1997;283:1412-1424.
38. Steinberg GK, Panahian N, Perez-Pinzon MA, Sun GH, Modi MW, Sepinwall J. Narrow temporal therapeutic window for NMDA antagonist protection against focal cerebral ischemia. Neurobiol Dis. 1995;2:109-118.